NeuroOne Medical Technologies (NASDAQ:NMTC) Announces Quarterly Earnings Results

NeuroOne Medical Technologies (NASDAQ:NMTC) released its quarterly earnings results on Tuesday. The company reported ($0.11) EPS for the quarter, Zacks reports. NeuroOne Medical Technologies had a negative net margin of 308.51% and a negative return on equity of 276.12%.

NeuroOne Medical Technologies Stock Performance

NeuroOne Medical Technologies stock opened at $0.76 on Tuesday. NeuroOne Medical Technologies has a fifty-two week low of $0.55 and a fifty-two week high of $1.72. The company has a market cap of $23.31 million, a PE ratio of -1.58 and a beta of 0.54. The business’s 50-day simple moving average is $0.82 and its two-hundred day simple moving average is $0.84.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.